Qualigen Therapeutics

QLGN64

Penny Stock

$3.69arrow_drop_up2.49%$0.08

Penny Stock

QLGN64

$3.69

arrow_drop_up2.49%$0.08

Penny Stock

Performance History

Key Stats
Open	$3.73
Prev. Close	$3.60
EPS	-82.00
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$2.65M
PE Ratio	-

	LOW	HIGH
Day Range	3.69	4.50
52 Week Range	0.08	5.23

Ratios

Revenue	-





EPS	-82.00

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Qualigen Therapeutics (QLGN)

Qualigen Therapeutics, Inc. (QLGN) is a biotechnology company that specializes in the development and commercialization of novel therapeutic products for the treatment of various diseases. The company's mission is to improve the lives of patients through the discovery and development of innovative therapies. With a focus on precision medicine, Qualigen Therapeutics is dedicated to delivering personalized treatments that target specific genetic abnormalities or biomarkers associated with diseases.

One of the key products in Qualigen Therapeutics' pipeline is its drug candidate ALAN, which is being developed for the treatment of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). ALAN is a targeted therapy that works by inhibiting a specific enzyme that is overexpressed in cancer cells. By targeting this enzyme, ALAN is designed to block the growth and proliferation of cancer cells while minimizing damage to healthy cells.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Michael S. Poirier
Headquarters: Carlsbad
Employees: 31
Exchange: NASDAQ

Keep an eye on Qualigen Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Qualigen Therapeutics's (QLGN) price per share?

The current price per share for Qualigen Therapeutics (QLGN) is $3.69. The stock has seen a price change of $0.09 recently, indicating a 2.5% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Qualigen Therapeutics (QLGN)?

For Qualigen Therapeutics (QLGN), the 52-week high is $5.24, which is 41.87% from the current price. The 52-week low is $0.08, the current price is 4.38K% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Qualigen Therapeutics (QLGN) a growth stock?

Qualigen Therapeutics (QLGN) has shown an average price growth of -6.65% over the past three years. It has received a score of 91 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Qualigen Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Qualigen Therapeutics (QLGN) stock price performance year to date (YTD)?

As of the latest data, Qualigen Therapeutics (QLGN) has a year-to-date price change of -86.68%. Over the past month, the stock has experienced a price change of -53.93%. Over the last three months, the change has been -65.91%. Over the past six months, the figure is -74.81%.

help

Is Qualigen Therapeutics (QLGN) a profitable company?

Qualigen Therapeutics (QLGN) has a net income of -$12.48M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 4.44%, providing insight into the company's sales performance and growth. Operating income is noted at -$11.3M. Furthermore, the EBITDA is -$8.33M.

help

What is the market capitalization of Qualigen Therapeutics (QLGN)?

Qualigen Therapeutics (QLGN) has a market capitalization of $2.65M. The average daily trading volume is 3.92, indicating the stock's liquidity and investor engagement.